Published January 20, 1976 | Version v1
Patent Open

Composition comprising radioactive labeled-fibrinogen and albumin

Creators

Description

The stability of fibrinogen is improved by mixing it with albumin, preferably at least 5 parts by weight of albumin per part by weight of fibrinogen. By this invention, iodinated (125I) human fibrinogen can be stabilized with human serum albumin for use in the diagnosis of thrombi

Availability note (English)

MF available from INIS under the Report Number.

Files

7268543.pdf

Files (259.8 kB)

Name Size Download all
md5:211d8e939d80cfd50ea684e05cb2da46
259.8 kB Preview Download

Additional details

Additional titles

Augmented title (English)
"1"2"5I tracer technique

Publishing Information

Imprint Pagination
6 p.
IPC:
Int. Cl.A61K43/00; A61K35/16; A61K37/02.
IPC
Int. Cl.A61K43/00; A61K35/16; A61K37/02.
Patent number
US patent document 3,933,996

INIS

Country of Publication
United States
Country of Input or Organization
United States
INIS RN
7268543
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ALBUMINS; DIAGNOSIS; FIBRINOGEN; IODINE 125; LABELLING; THROMBOSIS; TRACER TECHNIQUES
Descriptors DEC
BETA DECAY RADIOISOTOPES; BLOOD COAGULATION FACTORS; CARDIOVASCULAR DISEASES; DAYS LIVING RADIOISOTOPES; DISEASES; ELECTRON CAPTURE RADIOISOTOPES; GLOBULINS; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPE APPLICATIONS; ISOTOPES; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; PROTEINS; RADIOISOTOPES